Data Collection Under The Sunshine Act

by Carlton Fields

Data collection requirements under the Physician Payment Sunshine Act commenced August 1, 2013. This provision of the Patient Protection and Affordable Care Act and the corresponding regulations require an entity that is engaged in the production, preparation, propagation, compounding or conversion of drugs, medical devices, biologics or medical supplies to track and annually report payments or other transfer of value of over $10 to physicians and teaching hospitals. 42 U.S.C. § 1320a-7h(a). The Sunshine Act additionally requires that these entities, also referred to as “applicable manufacturers,” as well as group purchasing organizations (GPO) to report certain ownership and investment interests held by physicians or their family members in such entities. Id.

Reporting of Data and Deadlines
The information collected by these manufacturers and GPOs must be electronically submitted annually to the Secretary of the Department of Health and Human Services (HHS), which will make the information publicly available. Id.  Applicable manufacturers and GPOs that are required to submit a report pursuant to this rule must register with the Centers for Medicare and Medicaid (CMS) within 90 days of the end of the calendar year for which a report is required. 42 C.F.R. § 403.908(c). The first reporting deadline is March 31, 2014. 42 C.F.R. § 403.908(a).  Applicable manufacturers, GPOs, physicians, teaching hospitals, and physician owners or investors in such entities will be afforded at least 45 days to review and submit corrections to the information submitted before CMS makes the information available to the public. 42 U.S.C. § 1320a-7h(c)(1)(C)(ix); 42 C.F.R. § 403.908(g). Despite this 45 day period, the information could still be made available to the public. Id.

Exceptions to the Reporting Requirements
The regulations published by CMS delineate specific exceptions to the reporting requirements, which include but are not limited to: (1) certain indirect payments or other transfers of value; (2) product samples not intended for sale; (3) educational materials for the benefit of the patients; (4) short-term loans of a device not to exceed 90 days for the evaluation of the physician or teaching hospital; and (5) discounts and rebates for drugs, devices, biological and medical supplies provided by applicable manufactures to physicians or teaching hospitals. 42 C.F.R. § 403.904(i).

Penalties for Non-Compliance with Reporting Requirements
Penalties for non-compliance with these reporting deadlines can result in fines between $1,000 and $10,000 for each violation, not to exceed $150,000. 42 U.S.C. § 1320a-7h(b)(1). A knowing failure to report, however, can result in civil monetary penalties ranging from $10,000 to $100,000 for each unreported payment or other transfer of value or ownership, not to exceed 1,000,000. 42 U.S.C. § 1320a-7h(b)(2). The Sunshine Act utilizes the “knowing” standard contained in the False Claims Act for purposes of the imposition of the latter civil monetary penalties. 42 U.S.C. § 1320a-7h(e)(8); 31 U.S.C. § 3729(b)(1).

Considerations Moving Forward
To prepare for these new requirements, applicable manufacturers should consider how they will identify and report payments. Given the penalties for non-compliance, it is essential to have policies and procedures in place to identify payments, document the justification for the payments, confirm the accuracy of the information and report the information. In addition, manufacturers should determine how to inform health care providers of its policies and procedures. The health care providers should implement a manner to document this information as well, so as to verify the accuracy of the information being reported by these manufacturers.

Furthermore, in developing these policies and procedures applicable manufacturers, GPOs and health care providers alike should keep in mind that this information could be sought during discovery in civil medical malpractice litigation. The information could be sought to assert physician motive for medical decision making, or even to try to hold the manufacturing industry liable for the actions of the physician recipient. 

Finally, compliance with these reporting requirements does not relieve or exempt applicable manufacturer, GPOs or physician owners or investors from potential liability for payment or other transfers of value pursuant to the Federal Anti-Kickback Statute (AKS) or the False Claims Act (FCA) and the equivalent state laws. It should be equally noted that because this reporting requirement carries little burden of proof – simply proving a lack of reporting – it may be increasingly utilized in conjunction with AKS or FCA lawsuits.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Carlton Fields | Attorney Advertising

Written by:

Carlton Fields

Carlton Fields on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.